MedTrace Logo

Observational Study of Ketamine Infusions for the Treatment of Chronic Pain

NCT05477004 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2025-12-19

No results posted yet for this study

Summary

This observational study will collect prospectively specified data on patient characteristics and clinically relevant outcomes in patients who receive a ketamine infusion at Stanford Pain Management Center for the treatment of chronic pain, with the goal of identifying treatment responders and relationships between patient characteristics and treatment response.

Conditions

Interventions

DRUG

Ketamine

A multi-day continuous ketamine infusion delivered intravenously at subanesthetic doses in a monitored setting

Sponsors & Collaborators

  • Theresa Lii

    lead OTHER

Principal Investigators

  • Theresa Lii, MD · Stanford University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-01
Primary Completion
2026-12-31
Completion
2026-12-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05477004 on ClinicalTrials.gov